Northpond Ventures, LP
Insider CIK 1867472 · ISO 10% owner · DICE 10% owner · CAMP 10% owner · VIGL 10% owner · DNAY Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-17 | 5,287,303 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-17 | 11,251,624 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-17 | 763,636 | $11.00 | $8.40M | 763,636 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-17 | 471,415 | — | $0 | 471,415 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-17 | 1,003,193 | — | $0 | 1,003,193 | SEC↗ |
| DICE DICE Therapeutics, Inc. | S Sale | 2023-06-22 | 2023-06-23 | 523,503 | $46.50 | $24.34M | 166,293 | SEC↗ |
| DICE DICE Therapeutics, Inc. | S Sale | 2023-06-22 | 2023-06-23 | 1,969,368 | $46.50 | $91.58M | 633,707 | SEC↗ |
| TBIO Telesis Bio Inc. | A Award deriv | 2023-06-05 | 2023-06-07 | 1,692,549 | — | $0 | 1,692,549 | SEC↗ |
| TBIO Telesis Bio Inc. | A Award deriv | 2023-06-05 | 2023-06-07 | 3,385,097 | — | $0 | 3,385,097 | SEC↗ |
| TBIO Telesis Bio Inc. | A Award deriv | 2023-06-05 | 2023-06-07 | 80,000 | $100.00 | $8.00M | 3,385,097 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 2,831,520 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 1,027,978 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 2,831,520 | — | $0 | 2,831,520 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 1,027,978 | — | $0 | 1,027,978 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-01-11 | 2022-01-11 | 355,000 | $14.00 | $4.97M | 1,382,978 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion deriv | 2021-10-12 | 2021-10-14 | 309,131 | — | $0 | 0 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion deriv | 2021-10-12 | 2021-10-14 | 191,108 | — | $0 | 0 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion deriv | 2021-10-12 | 2021-10-14 | 130,006 | — | $0 | 0 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion deriv | 2021-10-12 | 2021-10-14 | 287,785 | — | $0 | 0 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion | 2021-10-12 | 2021-10-14 | 1,040,048 | — | $0 | 1,080,961 | SEC↗ |
| ISO IsoPlexis Corp | P Buy | 2021-10-12 | 2021-10-14 | 1,000,000 | $15.00 | $15.00M | 2,080,961 | SEC↗ |
| ISO IsoPlexis Corp | C Conversion | 2021-10-12 | 2021-10-14 | 6,304,192 | — | $0 | 6,727,570 | SEC↗ |
| DICE DICE Therapeutics, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-20 | 1,735,388 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-20 | 454,796 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-20 | 867,687 | — | $0 | 0 | SEC↗ |
| DICE DICE Therapeutics, Inc. | P Buy | 2021-09-17 | 2021-09-20 | 235,000 | $17.00 | $4.00M | 3,292,871 | SEC↗ |
| DICE DICE Therapeutics, Inc. | C Conversion | 2021-09-17 | 2021-09-20 | 2,603,075 | — | $0 | 2,603,075 | SEC↗ |
| DICE DICE Therapeutics, Inc. | C Conversion | 2021-09-17 | 2021-09-20 | 454,796 | — | $0 | 3,057,871 | SEC↗ |
| DNAY Codex DNA, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-24 | 5,214,851 | — | $0 | 0 | SEC↗ |
| DNAY Codex DNA, Inc. | C Conversion deriv | 2021-06-22 | 2021-06-24 | 4,160,529 | — | $0 | 0 | SEC↗ |
| DNAY Codex DNA, Inc. | C Conversion | 2021-06-22 | 2021-06-24 | 9,375,380 | — | $0 | 9,375,380 | SEC↗ |
| DNAY Codex DNA, Inc. | P Buy | 2021-06-22 | 2021-06-24 | 468,750 | $16.00 | $7.50M | 9,844,130 | SEC↗ |